|
|
Volumn 3, Issue 1, 2001, Pages 27-32
|
|
Genetic factors in ovarian carcinoma.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BRCA1 PROTEIN;
BRCA2 PROTEIN;
TUMOR SUPPRESSOR PROTEIN;
CANCER STAGING;
COMPARATIVE STUDY;
FEMALE;
GENE EXPRESSION REGULATION;
GENETIC PREDISPOSITION;
GENETICS;
HUMAN;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
ONCOGENE RAS;
OVARY TUMOR;
PROGNOSIS;
PROTO ONCOGENE;
REVIEW;
SENSITIVITY AND SPECIFICITY;
SURVIVAL;
TUMOR SUPPRESSOR GENE;
BRCA1 PROTEIN;
BRCA2 PROTEIN;
COMBINED MODALITY THERAPY;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENES, ERBB-2;
GENES, P53;
GENES, RAS;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
NEOPLASM STAGING;
OVARIAN NEOPLASMS;
PROGNOSIS;
SENSITIVITY AND SPECIFICITY;
SURVIVAL ANALYSIS;
TUMOR SUPPRESSOR PROTEINS;
|
|
EID: 0002014682
PISSN: 15233790
EISSN: None
Source Type: Journal
DOI: 10.1007/s11912-001-0039-y Document Type: Review |
|
Times cited : (26)
|
|
References (42)
|
